![Eric Haltom](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Eric Haltom worked as a Senior Vice President-Clinical Operations at Deciphera Pharmaceuticals, Inc. from 2016 to 2021.
Anciens postes connus de Eric Haltom
Sociétés | Poste | Fin |
---|---|---|
DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Deciphera Pharmaceuticals, Inc.
![]() Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |